» The Role of PARP Inhibition in Prostate Cancer: e-Learning Now Available

The Role of PARP Inhibition in Prostate Cancer: e-Learning Now Available

Prof. Emmanuel S. Antonarakis, Dr. Neal D. Shore, Prof. Andrew J. Armstrong

The range of therapeutic options in prostate cancer is expanding, including strategies for PARP inhibition.

Prof. Emmanuel S. Antonarakis

Medical Oncologist

Johns Hopkins Medicine

United States (US)

Dr. Neal D. Shore

Urologist

Carolina Urologic Research Centre and GenesisCare

United States (US)

Prof. Andrew J. Armstrong

Medical Oncologist

Duke University School of Medicine

United States (US)

Dr. Neal D. Shore

Urologist

Carolina Urologic Research Centre and GenesisCare

United States (US)

Neal D. Shore, MD, FACS is the Medical Director for the Carolina Urologic Research Center. He practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr. Shore has conducted more than 350 clinical trials, focusing mainly on GU Oncology, and serves on the Executive Boards of: Society of Urologic Oncology Board, Bladder Cancer Advocacy Network, and is Immediate Past President, Large Urology Group Practice Association. He is a founder for both: CUSP Clinical Trials Consortium, as well as for DASHKO, large urology practices data registries. He serves as the National Urology Research Director for 21st Century Oncology. He has served on the AUA Male Health Committee and the AUA Data Committee, the SITC Task Force for Prostate Cancer, the Bladder Cancer Advocacy Think Tank and the editorial boards of Reviews in Urology, Urology Times, Chemotherapy Advisor, OncLive, PLOS ONE(Academic Editor), Urology Practice, World Journal of Urology, and serves as Editor, Everyday Urology-Oncology. He has more than 200 peer reviewed publications and numerous book chapters; he performs peer review for Lancet Oncology, New England Journal of Medicine, European Urology, Journal Urology, Urology, BJUI, PCPD, and numerous other high impact scientific journals. A graduate of Duke University and Duke University Medical School, Dr. Shore completed a 6-month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons.

Dr. Neal D. Shore has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

time E-learning | open 60 min |accreditation: EACCME | Aug 2020

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

download resources

PDF FILE

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

The aim of this e-learning course is to provide an understanding of the mechanism of action of PARP inhibitors; the prevalence of DNA damage repair (DDR) mutations in advanced prostate cancer, as well as approaches for somatic and germline testing to identify patients with these mutations; and the recent and ongoing clinical trial data on PARP inhibition in advanced prostate cancer. Watch this video from Dr. Neal D. Shore and download the educational slides to learn more. Follow the link above to start your e-learning journey today.

This course has been developed by the following expert faculty:

Dr. Neal D. Shore, Carolina Urologic Research Center (Myrtle Beach, South Carolina, USA)
Prof. Andrew J. Armstrong, Duke University School of Medicine (Durham, North Carolina, USA)
Prof. Emmanuel S. Antonarakis, Johns Hopkins Medicine (Baltimore, Maryland, USA)

This course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) and ECMEC® is available. Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.

Other programmes of interest

COR2300 - TEST 2

0 min

COR2300 - TEST 2

Oct 2023

COR2300 - TEST 1

0 min

COR2300 - TEST 1

Oct 2023

TEST

15 min

TEST

Oct 2023

Prof Valentina Guarneri

Interactive patient case

28 min

(TEST) Oral SERDs: New Endocrine Therapy Options in ER+ Advanced ...

Sep 2023

dsfdsfsdfd

15 min

dsfdsfsdfd

Sep 2023

Join COR2ED as we celebrate 10 years of excellence in independent medical education

Other

3 min

Join COR2ED as we celebrate 10 years of excellence in independent...

Sep 2023

Prof. Viktor Grünwald

Interactive patient case

11 min

Optimising treatment for advanced RCC

Jun 2023

Prof Frédérique PENAULT-LLORCA

Prof. Dr. Ángel Cequier Fillat

Prof. Dr. Zuzana Motovska

Other

104 min

UPDATE FROM ASCO 2023

May 2023

EARLY REGISTRATION DEADLINE: APRIL 26 AT 11:59 PM (ET)

Survey

0 min

EARLY REGISTRATION DEADLINE: APRIL 26 AT 11:59 PM (ET)

May 2023

234

0 min

234

Apr 2023

Jira Atlassian access

Apr 2023

Testing media

Connect

0 min

Testing media

Mar 2023

Other programmes developed by Dr. Neal D. Shore

Dr. Neal D. Shore

Urologist

Carolina Urologic Research Centre and GenesisCare

United States (US)

Assoc. Prof. Alicia Morgans

Dr. Neal D. Shore

Podcast

40 min

Prostate Cancer Highlights from ASCO GU 2022

Mar 2022

Image of Drs. Tanya Dorff, Phillip Koo and Neal Shore

Dr. Neal D. Shore

Assoc. Prof. Tanya Dorff

Dr. Phillip Koo

Podcast

30 min

Accreditation: EACCME

Radiopharmaceuticals in prostate cancer - radium-223 (Episode 1 o...

May 2021

Dr. Neal D. Shore

5 min

Optimising treatment sequence for mCRPC after intensified therapy...

Jul 2021

Dr. Neal D. Shore

5 min

Update from ASCO GU 2019 #1

2019

Dr. Neal D. Shore

5 min

GU CONNECT Prostate Cancer Update from ASCO GU 2020 (1 of 3)

Feb 2020

Dr. Neal D. Shore

Assoc. Prof. Alicia Morgans

Webinar

35 min

Prostate Cancer Management Masterclass: mCSPC Plenary Session 1

Dec 2020

Dr. Neal D. Shore

Assoc. Prof. Alicia Morgans

Assoc. Prof. Tanya Dorff

And others...

5 min

Prostate Cancer Management Masterclass: An Introduction

Dec 2020

Dr. Elena Castro

Dr. Neal D. Shore

Dr. Daniel Keizman

And others...

5 min

The role and place of genetic testing in prostate cancer

Mar 2021

Prof. Emmanuel S. Antonarakis

Dr. Neal D. Shore

Prof. Andrew J. Armstrong

5 min

The Role of PARPi in Prostate Cancer: Experts Knowledge Share

Aug 2020

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.